Following a one-month prospective study of antimicrobial drug use in surgical departments, new guidelines were implemented. The review was repeated after two years. In both study periods, one third of patients were prescribed antimicrobial drugs. Prophylactic antibioticconsumption decreased from 0.75 to 0.53 defined daily doses/operation. Compliance with guidelines improved from 32% to 79%. Duration of prophylaxis >24 h decreased from 21% to 8%. Single dose prophylaxis increased from 34% to 80%, Quality of the prophylactic courses improved, as evaluated by experts using established criteria. For prophylaxis, cost savings amounted to 57%. Better quality of therapeutic courses was associated with a cost increase of 15%. Indicators of satisfactory outcome with the new policy were a stable median length of stay (5.5 days in the first review and 5,0 days after intervention) and a reduction in the number of nosocomial infections treated with antimicrobial drugs/100 bed days (1.0 before intervention vs 0.77 after intervention).
Introduction
Antimicrobial drugs account for 13-37% of the drug budget in European hospitals (Hekster & Barrett, 1987) ; 30-60% of the courses are for prophylactic use (Maki & Schuna, 1978; Nickman, Blissenbach & Herrick, 1984) , The main reasons for monitoring antimicrobial drug use are to optimise medical care, to limit and reduce the spread of resistant microorganisms and to contain costs. In Europe, the pressure to reduce costs is still increasing in countries with budgeting systems, such as in the Netherlands. In addition to a concern about increasing costs of antimicrobial drugs, many authors have described inappropriate use (Kunin et al,, 1990; Dimagan et al 1991) , Surgical prophylaxis with antimicrobial drugs is long known as an area where overuse is often found and where it is also the easiest to correct (Smith et al., 1988; Galandiuk et al., 1989) . Many antimicrobial drugs intervention strategies are described to optimise quality at lesser cost, including the development of protocols (Marr, Moffet & Kunin, 1988) , A number of criteria for optimal therapy and prophylaxis are well established (Kunin, Tupasi & Craig, 1973; Gyssens et al., 1992) , A widely accepted regimen of preoperative prophylaxis is 1 g of the first generation cephalosporin cephazolin, given within an optimal period before incision, and repeated if the operation lasts for more than 3 h (Abramowicz, 1989; Classen et al., 1992) . We conducted a prospective intervention study in three surgical departments in a large university hospital: to define antimicrobial drug use (prophylaxis and therapy) in terms of quality and costs; and to measure the effect of interventions to improve the quality of antimicrobial drug courses.
Patients and methods

Setting
The University Hospital Nijmegen is a 948-bed teaching hospital with 344 surgical beds, and approximately 1600 operations/month on in-patients. The study took place in the departments of gynaecology and obstetrics (G), surgery (S) and orthopaedic surgery (O) . The hospital formulary listed 20 parenteral and 26 oral antibacterial drugs at the start of the study. In the previous year, antimicrobial drugs accounted for 22% of the hospital drug budget of Dfl 14 million (£5.3 million). The Antibiotics Committee had issued a new edition of an antimicrobial drug formulary. In addition, some surgical departments had their own treatment protocols. We refer to both as 'guidelines'. The classification of Cruse & Foord (1980) for surgical procedures was used with adaptations (Abramowicz, 1989) . Length of stay was calculated as follows: number of in-hospital days of patients included in the study/number of patients included in the study.
Antimicrobial drug use review
The first review took place during separate one-month study periods in 1990. Antimicrobial drug use was reviewed in 766 consecutive surgical patients. After a period of intervention, a similar review of 744 consecutive patients was repeated in 1992. The studies were performed by an infectious diseases physician and junior clinical pharmacists, who collected data daily on all patients receiving antimicrobial drugs. Abstracts were made o f each course. A course was defined as an episode of clinical or suspected infection or increased risk of infection, in which prescription(s), either consecutively or in combination, were written as treatment or prophylaxis. Clinical information was retrieved from the patients' records. Infections were defined according to the Centers of Disease Control (Garner et ai, 1988) . Nosocomial infection was defined as active infection that was not present or incubating at the time of admission. Microbiology results were obtained directly from the laboratory. The schedule of systematic antimicrobial drug treatment was copied from the medication chart and from the anaesthesia record.
Antimicrobial drug use was converted into Defined Daily Doses (DDD). The DDD represents the average therapeutic dose for an adult for the standard indication (Anonymous, 1982) . Quantitative use was analysed by calculating the num ber of courses in the population at risk in the study periods (courses/100 bed days, incidence rate) and by comparing D D D /100 bed days. The D D D /100 bed days has been chosen by the WHO Drug Utilization Research Group as a unit of comparison between hospitals (Bergman et a l 1979) . Direct and indirect costs were calculated in Dutch guilders (Dfll = £0.38) by a method for global drug cost calculation, which includes costs of drug administration and costs of monitoring (Gyssens et al., 1991) , Qualitative use was analysed in two ways. First, compliance with existing hospital guidelines was checked at the time of the initial review, and compliance with the department's new protocol after the intervention. Second, two independent experts in infectious diseases (termed reviewer 1 and reviewer 2) evaluated quality in the following way: prescriptions were assessed using six categories of antimicrobial use by means of established criteria arranged in a flow chart. The method is based on the original criteria of Kunin et al. (1973) and is described previously (Gyssens et a l 1992) . In short, prescriptions can be definitely appropriate (category I), unjustified (category V) or the records insufficient for categorization (category VI). The other prescriptions are placed in categories of inappropriate use II, III, and IV. Inappropriate prescriptions can be allocated to several categories at the same time: incorrect dose (Ila), interval (lib) or route (lie), duration too long (Ilia) or too short (Illb). If relevant, the experts cite a better alternative agent for reasons of optimal effectiveness (using microbiological and pharmacodynamic criteria) (category IVa), lower toxicity (IVb), lower cost (IVc) or less broad spectrum (IVd). Global costs of actual and alternative policies (in this study the alternative policy proposed only by reviewer 1) were compared in order to estimate savings due to changes in policy. Reviewer 1 was chosen in this context for both simplicity and because he was the infectious diseases expert of the study centre.
Intervention
After the first review, reports were sent to the heads of each department. The report was accompanied by recommendations for the alternative antibiotic policy of reviewer 1, in accordance with the antimicrobial drug policy. The principal goal was to introduce a universal surgical prophylaxis standard of single-dose cephazolin at incision (with metronidazole if necessary to provide anti-anaerobe activity). The recommendations were adapted to new protocols with the help of a surgical staff member. After approval by the Antibiotics Committee, a presentation was held in the department, aided by the surgical staff member. In most departments, the first dose of antimicrobial prophylaxis was given by the anaesthetist in the operating room. Because anaesthesias were performed by a rotating pool of 40 anaesthetists (staff and residents), the departm ent of anaesthesiology was interviewed by means of a questionnaire. The inquiry showed deficient communication between anaesthetists and surgeons on the subject of administration and timing of antibiotic prophylaxis (Gyssens, Knape & Van der Meer, 1995) . The results of the inquiry were reported in an educational setting.
Implementation of the protocols was assisted by the department of clinical pharmacy. Junior pharmacists organized briefings for nurses, and the prophylaxis guidelines were displayed in the wards and operating rooms. Operating room drug stocks were reorganized. In departments S and O, pharmacy technicians discussed protocol violations with prescribers and nurses on their twice weekly visits to the wards, as a long term surveillance exercise.
Statistical analysis
Generally, chi-squared tests were applied to establish systematic differences. The Wilcoxon test was used for the comparison of lengths of hospital stay. Fisher's exact test was used to compare durations of prophylaxis. Agreement between the experts was assessed by k coefficients. Table I shows the characteristics of the study populations in the first and second study periods. The numbers of patients hospitalized and operations performed in the study periods, and the proportions of patients given antimicrobial drugs were similar in both reviews. The median length of hospital stay in the two study periods was not statistically different in departments G and S. In department O, the median length of stay decreased significantly (P -0.005). Mean patient age was 40.9 (range 2-88) and 43.4 (range 0-94) before and after the intervention, respectively. The proportion of parenteral antibiotic D D D s increased from 62% to 80%. Quantitative data were analysed in detail according to prophylaxis and therapy.
Results
Quantitative use
Prophylaxis. Thirty-nine prophylactic courses/100 operations were performed after intervention, compared with 34 courses/100 operations in the first review. However, the use o f prophylactic antimicrobial drugs expressed in DDD/operation decreased. After the intervention, only 16% of total use (in DDDs) was for prophylactic use, compared with 31% in the first review. Before intervention, a variety of antimicrobial drugs were used for prophylaxis in regimens lasting 24 h (Figure 1) .
W hen the medication order on the anaesthesia record mentioned "24 h" , some nurses in the wards did not take into account the antibiotic dose given by the anaesthetist in the operating room. This practice resulted in an extra dose in 10% (department O) and in 50% (department S) of the prescriptions for 24 h of prophylactic antibiotics. After the intervention, fewer regimens were used in favour of a single dose of cephazolin (plus metronidazole).
Therapy. Therapeutic courses/100 bed days decreased from 2.1 to 1.8. Abdominal (37%) and pelvic (40%)) infections were the most frequent type of infections treated with antibiotics in both reviews. Urinary tract infections accounted for 23% and 24% of infections in the two study periods. The number of nosocomial infections treated with antimicrobial drugs/100 bed days was 1.0 before intervention and 0.77 after intervention. There was an increase of DDD/therapeutic course from 8.8 to 17.1. The main reason for the increase was that the new protocols advised treatment of severe infections, such as osteomyelitis, with larger dosages and for longer periods.
The major changes in the therapeutic antimicrobial drugs prescribed are presented in Table II . After the intervention, narrow spectrum penicillins (penicillin G, flucloxacillin) were used more often in directed therapy. Penicillin use increased four-fold and prescription of iv cephalosporins increased by half. However, some changes occurred unexpectedly; for example, amoxycillin-clavulanate had been introduced in the new protocol of department G for the treatment of post-partum In the second review, amoxyciliin-clavulanate use had increased from 0 to 6.9 DDD/100 bed days and represented 39% of the departments' total therapeutic use.
Costs
Total (global) costs amounted to Dfl 37,448 (£14,131) before the intervention and to Dfl 33,289 (£12,562) in the second review, resulting in total cost savings of 11%. Projected annual savings amounted to Dfl 49,800 (£18,792). 
2.4 (13) 3.5 3.0 2.5 (8) Co-trimoxazole 2.9 1.9 1.8 (10) 1.2 2,7 1.4 2.0 (6) Ciprofloxacin Prophylaxis. The cost of prophylactic antibiotics was Dfl 13,376 (36% of the total antibiotic budget) in the first review and Dfl 5,725 (17%) after intervention. Figure 2 presents the total distribution of costs of prophylaxis by antimicrobial drug group before and after the intervention. Before the intervention, piperacillin, which accounted for 7% of the antibiotic consumption of department G, accounted for 34% of costs. In department S, clindamycin, which accounted for 16% of total use, accounted for 48% of costs. Potential savings in prophylaxis, calculated by the experts after the first review, were estimated at 83%. The savings realized in the second review am ounted to 57%. Prophylactic cost/operation was halved, from Dfl 2.2 to Dfl 1.1. Savings were mainly realized by replacing piperacillin (Dfl 44.9/single dose) and the regimen of gentamicin with clindamycin (Dfl 107.6/24 h course) by cephazolin (Dfl 6.3/single dose) with or without metronidazole (Dfl 6.1/single dose).
Therapy, After the intervention, overall costs of therapy increased by 15%. This increase was mainly due to higher dosage and longer duration of treatment. The drugs of the new protocol were often cheaper; after intervention, the cost/therapeutic D D D had decreased from Dfl 26.1 to Dfl 18.7. Part of the costs were still due to inappropriate prescriptions.
Qualitative aspects
Prophylaxis. After intervention, there was a higher overall compliance with the new protocols than with the old guidelines (P < 0.0001) (Table III) . The difference was significant in each of the three departments. Parameters of quality for prophylaxis improved; the use of a prophylactic course for >24h decreased significantly in department S but not in departments G or O. Single dose prophylaxis increased significantly in each of the three departments. The intervention also improved the timing of the first dose of antibiotic (administration within 1 h before surgical incision) in departments S and O, as reported previously (Gyssens et a l 1996) . Agreement (excepting category VI) between the two experts assessing quality of prophylaxis before and after intervention was very high in both reviews (k = 0.80). Therefore, only the assessment of one expert, reviewer 1, is discussed here and is presented in Table III . There were significant differences in quality before and after the intervention in departments G (P < 0.0001), S (P < 0.0001) and O (P -0.004). Table IV shows most frequent type of errors (evaluation categories II-V) by prophylactic drug before intervention. Oral cephalexin prophylaxis started post-operatively and continued for five days was considered unjustified (category V). Oral prophylaxis with neomycin/bacitracin was followed by iv gentamicin plus clindamycin at induction of anaesthesia in 15 of 28 courses. The oral prescriptions were judged unnecessary (category V). Moreover, the review revealed some erroneous practices. In department S, nurses administered neomycin/bacitracin to all patients undergoing a bowel purging procedure, including those patients due to have anorectal operations (category V). Most oral prophylaxis (use of oral plus iv regimens or postoperative) was abandoned after the intervention. Prophylaxis with piperacillin was considered to be too Table III . Quality parameters of antimicrobial drug prophylaxis in three surgical departments.
See Table I for legend broad and expensive (category IV c, d). Overall, 39% of prophylactic prescriptions were judged unjustified. Their cost represented 28% of total cost of prophylactic antibiotics (Table IV) and 66% of the predicted cost savings with the alternative policy proposed by reviewer 1.
Therapy. Overall agreement between the two reviewers was much lower for therapy, both before (ic = 0.37) and after (k = 0.30) intervention. New protocols were based on the alternative policy of reviewer 1. Considering the overall evaluation of 224 and 169 therapeutic prescriptions of the three departments, before and after intervention by reviewer 1, respectively, the proportion of prescriptions that were considered definitely appropriate (category I) increased from 70 (31%) to 80 (47%). Prescriptions unjustified for therapy (category V) decreased from 35 (16%) to 14 (8%). Inappropriate prescriptions accounted for 100 (45%) and 61 (36%), respectively (P = 0.007).
Discussion
From the initial review we concluded that antimicrobial drug use in the surgical departments could be improved both in terms of quality and costs. In our hospital, major misuse such as prophylaxis >48 h or a combination of more than three antibiotics (Kunin et al., 1973) was seldom encountered. Non-compliant physicians were rare.
The intervention succeeded in implementing a widely accepted regimen o f single dose antibiotic (cephazolin ± metronidazole) for surgical prophylaxis. This type of intervention has been successful in departments of gynaecology and obstetrics (Smith et a l 1988; Everitt et al., 1990) . The contribution of parenteral clindamycin to costs is considerable (Kunin, 1985) , and its replacement by metronidazole is known to be cost-containing (Fletcher et a l 1990) . We implemented the regimen in several surgical specialties for all procedures where prophylaxis was deemed appropriate. The intervention included the education of anaesthetists, nurses and surgeons. The preparation and acceptance of the new guidelines took several months. At implementation, however, the effect was sometimes immediate, for example, by changing the operating room drug stock. The regimen replaced a variety of broad spectrum antimicrobial drugs, previously chosen on the basis of personal preferences and possibly the result of promotional efforts by pharmaceutical companies. Prophylaxis with cephazolin was generally cheaper, even in combination with metronidazole (Gyssens et al., 1991) . Cost-containment was also obtained by shortening the duration of prophylaxis. Compliance with guidelines improved, as did the result of the evaluation by the experts. Both reviewers largely agreed upon the improvement of quality of prophylaxis.
Improvement in the quality of therapeutic antibiotic prescribing was less striking, and was achieved at higher cost. There was limited agreement between the two experts concerning the quality of surgical therapy. Reviewer 2 judged less therapeutic prescriptions appropriate and more prescriptions unjustified, both before and after the intervention. However, his assessment also changed significantly after the intervention (data not shown). Correction of undertreatment of severe infections increased costs.
Reviews of this type are time consuming. However, the in-depth analysis detected m any logistic problems, solutions to which seemed crucial for the successful implementation of adequate prophylaxis. Organizational aspects were of major importance, as others described recently in the U K (Dobrzanski et al., 1991) . The in-depth analysis also detected problems with specific antibiotics. We used DDDs as a unit of measurement to allow international comparison of the utilization data. However, the main problem with DDDs in hospitalized patients is that the Prescribed Daily Dose (PDD) for certain antibiotics can be quite different from the D D D depending on the indication. When DDDs are used as a unit of measurement for single dose antibiotic surgical prophylaxis low usage figures result. For prophylaxis, the D D D /100 bed days underestimates the population exposed, whereas for severe infections the number of patients treated with the antibiotic is overestimated. The latter may partly explain why in all surgical departments, due to previous underuse, therapeutic antibiotic use defined in DDDs increased, and yet the same proportion of patients were treated. The overall proportion of patients receiving prophylaxis increased slightly, but more o f these prescriptions were judged appropriate. There was no systematic registration of wound infections during the study periods, and therefore we cannot fully assess the relative efficacies of prophylaxis regimens.
We conclude that this intervention resulted in an optimisation of the quality of prophylactic and therapeutic antimicrobial regimens in surgical departments at a lower cost. Indicators of satisfactory outcome with the new policy were a stable median length of hospital stay and a reduction in the number of nosocomial infections treated with antimicrobial drugs/100 bed days.
